Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03673527
PHASE1

Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin

Sponsor: LEO Pharma

View on ClinicalTrials.gov

Summary

This is a phase I trial to evaluate tacrolimus blood levels after topical application of tacrolimus twice daily on healthy skin.

Official title: Open-label, Non-randomised, Single-centre, Multiple-dose, Phase 1, Pharmacokinetic Trial With a Topical Formulation of Tacrolimus in Healthy Subjects

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2018-11-22

Completion Date

2019-02-11

Last Updated

2026-04-28

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

topical formulation of tacrolimus

Topical application of tacrolimus twice daily for 14 days (one dose on Day 14).

Locations (1)

Investigational site

Neu-Ulm, Bavaria, Germany